論文 - 田中 寿志
-
Efficacy and safety findings of the EXTRA study in older adult EGFR-mutant lung cancer patients receiving afatinib as first-line treatment.
Morikawa K, Takata S, Tanaka H, Itani H, Ishihara M, Horiuchi K, Kato Y, Ikemura S, Nakagawa H, Nakahara Y, Seki Y, Bessho A, Takahashi N, Hayashi K, Endoh T, Takeyama K, Maekura T, Takigawa N, Kawase A, Endoh M, Nemoto K, Kishi K, Soejima K, Okuma Y, Yoshimura K, Saigusa D, Kanai Y, Ueda K, Togashi A, Matsutani N, Seki N
Scientific reports 16 ( 1 ) 2026年02月
-
The gut microbiota as a potential biomarker in patients with EGFR-mutant lung cancer.
Tabe C, Motooka D, Fujita T, Makiguchi T, Taima K, Tanaka H, Itoga M, Ishioka Y, Akita T, Ishidoya M, Chubachi K, Fukushima T, Tanaka Y, Odagiri H, Kameyama Y, Kobori Y, Tasaka S, Fujii H
Scientific reports 16 ( 1 ) 1672 2025年12月
-
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations.
Hata T, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Matsumoto S, Honda R, Date K, Chihara Y, Kawachi H, Morimoto K, Takayama K.
Clin Lung Cancer. 2025年12月
-
Efficacy and safety of immune checkpoint inhibitors in advanced non-small cell lung cancer with idiopathic interstitial pneumonia or interstitial lung abnormalities: NJLCG2301.
Okumura F, Tanaka H, Onodera K, Morita R, Inomata M, Suzuki A, Sugisaka J, Minemura H, Jingu D, Kudo S, Kikuchi H, Yoshimura N, Tsushima F, Kakeda S, Tasaka S
Translational lung cancer research 14 ( 11 ) 4756 - 4767 2025年11月
-
Reversible ST-T Segment Changes Induced by Anamorelin: A Case Report.
Akaishi H, Makiguchi T, Ishida Y, Shimanaka T, Tanaka H, Taima K, Tasaka S
Respirology case reports 13 ( 11 ) e70398 2025年11月
-
A phase II study of afatinib in combination with pemetrexed and carboplatin in patients with EGFR mutation-positive non-squamous, advanced non-small cell lung cancer (NSCLC) refractory to first-line osimertinib treatment: NEJ025B study.
Nagashima H, Fukuhara T, Utsumi Y, Suzuki A, Miyanaga A, Seike M, Azuma K, Asahina H, Kisohara A, Kawashima Y, Tanaka H, Kanemaru R, Miyauchi E, Furuya N, Sato H, Nakashima K, Watanabe S, Sakai K, Nishio K, Takahashi F, Kobayashi K, Maemondo M
European journal of cancer (Oxford, England : 1990) 229 115693 - 115693 2025年10月
-
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study.
Morimoto K, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Hata T, Matsumoto S, Honda R, Date K, Chihara Y, Takayama K
International journal of clinical oncology 30 ( 10 ) 1963 - 1971 2025年10月
-
Cyclical Hemoptysis in a Patient With Right Lower Lobe Opacity Published online
Shintaro Oyama, Tomonori Makiguchi, Yasuhito Nunomura; Shunta Mukai Kengo Tani, Takahiro Sasaki, Daisuke Kimura, Masamichi Itoga, Hisashi Tanaka, Kageaki Taima, Sadatomo Tasaka.
CHEST® Pulmonary 2025年09月
-
CT所見を欠いたものの，経気管支肺生検で診断に至ったATTRアミロイドーシスの1例
小堀 由璃, 當麻 景章, 髙畑 友莉菜, 千葉 俊介, 福島 聖菜, 亀山 悠子, 小田切 遥, 牧口 友紀, 田中 寿志, 田坂 定智
気管支学 47 ( 5 ) 444 - 448 2025年09月
-
J-REGISTER: real-world study of Japanese patients with EGFR mutation-positive NSCLC treated with first-line afatinib.
Yamaguchi T, Daga H, Tanaka H, Kijima T, Mizushima M
Future oncology (London, England) 21 ( 16 ) 2039 - 2052 2025年07月
-
A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO).
Mitsunaga S, Naito T, Imai H, Kimura M, Miura S, Tanaka H, Mizukami T, Imoto A, Kondoh C, Okuyama H, Ueno M, Shiotsu S, Inano T, Chitose H, Tatematsu N, Okayama T, Mouri T, Sugiyama M, Omae K, Kawabata T, Mori K, Takayama K.
J Cachexia Sarcopenia Muscle. 2025年06月
-
Prolonged progression-free survival on epidermal growth factor receptor-tyrosine kinase inhibitors predicts superior response to atezolizumab-based therapy over chemotherapy in epidermal growth factor receptor-mutated non-small-cell lung cancer following progression.
Morimoto K, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Hata T, Matsumoto S, Honda R, Date K, Chihara Y, Takayama K
ESMO real world data and digital oncology 8 100152 2025年06月
-
Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim.
Makiguchi T, Odagiri H, Tanaka H, Taima K, Tasaka S
Thoracic cancer 16 ( 11 ) e70099 2025年06月
-
Prospective Multi-Institutional Observational Study of Retreatment with Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1/PD-L1 Plus Chemotherapy: NJLCG (North Japan Lung Cancer Group) Trial 1901.
Saito S, Kawashima Y, Tanaka H, Yoshimura N, Tsukita Y, Saito R, Nakagawa T, Inomata M, Nagashima H, Sugawara S
Cancers 17 ( 9 ) 2025年05月
-
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure.
Morimoto K, Yamada T, Furuya N, Tanaka H, Yoshimura A, Oba T, Hibino M, Fukuda T, Goto Y, Nakao A, Ogusu S, Okazaki Y, Harada T, Ota T, Masubuchi K, Mikami K, Hata T, Matsumoto S, Honda R, Date K, Chihara Y, Kawachi H, Takayama K
Targeted oncology 20 ( 3 ) 531 - 541 2025年05月
-
Prognostic impact of oligometastasis in older patients with extensive-stage small cell lung cancer.
Morinaga D, Hashimoto K, Asahina H, Tanaka H, Honjo O, Harada T, Yokouchi H, Kikuchi H, Shigaki R, Takashina T, Nakamura K, Kawai Y, Takahashi M, Kida R, Sukoh N, Ito K, Takahashi A, Hommura F, Ohhara Y, Furuta M, Konno S, Hosomi Y, Oizumi S
Respiratory investigation 63 ( 3 ) 373 - 382 2025年05月
-
Phase 2 Trial of Combination Radiotherapy and Pembrolizumab Plus Chemotherapy in Patients With Previously Untreated Metastatic NSCLC: NJLCG 1902.
Tsukita Y, Umezawa R, Nakagawa T, Anbai A, Makiguchi T, Tanaka H, Horii Y, Suzuki A, Morita R, Nogawa H, Yokouchi H, Kimura N, Jingu K, Inoue A, Sugiura H, Miyauchi E
JTO clinical and research reports 6 ( 5 ) 100817 - 100817 2025年05月
-
Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.
Hirano D, Fujimaru T, Sako M, Tanaka S, Inaba A, Uchimura T, Kamei K, Kubota T, Ohta T, Okamoto T, Tanaka H, Hamada R, Ito S
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 40 ( 5 ) 967 - 977 2025年04月
-
Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.
Fujimoto M, Yasuda H, Arai E, Nakajima M, Takata S, Morikawa K, Tanaka H, Itani H, Honda T, Horiuchi K, Watanabe K, Nakagawa H, Nakahara Y, Seki Y, Bessho A, Takahashi N, Hayashi K, Endo T, Takeyama K, Maekura T, Takigawa N, Kawase A, Endoh M, Nemoto K, Kishi K, Soejima K, Okuma Y, Togashi A, Matsutani N, Seki N, Kanai Y
Clinical epigenetics 17 ( 1 ) 63 2025年04月
-
Mycobacterium goodii pulmonary disease in an immunocompetent patient: A case report and literature review.
Shiratori T, Nunomura Y, Itoga M, Makiguchi T, Tanaka H, Taima K, Chikamatsu K, Kurose A, Mitarai S, Tasaka S
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 31 ( 4 ) 102665 2025年04月